An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia
Clinical trial NCT03989947 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03989947
- Sponsor
- BioMarin Pharmaceutical
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-12
- Primary completion
- 2038-05-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.